Lauren E. Colbert, MD MSCR (@colbertle) 's Twitter Profile
Lauren E. Colbert, MD MSCR

@colbertle

physician-scientist, GYN brachytherapist @mdandersonnews. #biostats nerd. we study tumor and vaginal #Microbiome, #HPV. Proud girl mom.

ID: 2772436785

linkhttps://www.mdanderson.org/research/departments-labs-institutes/labs/colbert-laboratory.html calendar_today16-09-2014 18:03:34

1,1K Tweet

1,1K Followers

1,1K Following

MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

A first-in-class antibody-drug conjugate works by targeting protein CD47, which helps immune cells activate and engulf cancer cells. The drug triggers an adaptive immune response to help eliminate the tumor. Learn more about the research, which Dr. Ben Schrank will present at

Adam Grippin (@adam_grippin) 's Twitter Profile Photo

Thanks to @MDAnderson for highlighting our work on #immunotherapy and #cancer #vaccines, and #ASTRO2024 organizers for sponsoring my trip with an abstract award! I’m excited to present data from the IMMUNOCERV trial led by fantastic mentors Ann Klopp, Lauren E. Colbert, MD MSCR and Olsi Gjyshi!

Chelsea C Pinnix MD PhD (@chelseapinnix) 's Twitter Profile Photo

Calling all #MedStudents here in gorgeous DC for #ASTRO24! Drop by the MD Anderson Cancer Center booth on Sunday 9/29 from 3-4 pm & meet our education faculty & residents to hear about residency training at MDACC. Emma B. Holliday MD Prajnan Das, MD, MS, MPH Albert Koong, MD PhD Jillian Gunther Comron Hassanzadeh

Jenna Kocsis (@jkocsismd) 's Twitter Profile Photo

Key takeaways from ARRO graduating resident survey 1️⃣ > 95% got the job type they wanted when they started the process (academic or private) 2️⃣ >90% satisfied with the job they signed 3️⃣ ~15% felt job market was tough this year. DOWN from ~70% in 2019-2020 #astro24

Stephanie Dudzinski MD, PhD (@stephdudzinski) 's Twitter Profile Photo

⭐️PGY3 Patrick P. Carriere, MD, PhD MD Anderson Cancer Center #radonc co-resident crushed his talk on pt-reported functional decline post-AS, RP, EBRT w/o ADT, or LDR at #ASTRO2024 ASTRO Great job, Patrick!!! 👏👏👏 & Excellent mentorship from Karen Hoffman, MD, MHSc, MPH 💪

⭐️PGY3 <a href="/dr_p_carriere/">Patrick P. Carriere, MD, PhD</a> <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> #radonc co-resident crushed his talk on pt-reported functional decline post-AS, RP, EBRT w/o ADT, or LDR  at #ASTRO2024 <a href="/ASTRO_org/">ASTRO</a> 

Great job, Patrick!!! 👏👏👏

&amp; Excellent mentorship from <a href="/KHoffmanMD/">Karen Hoffman, MD, MHSc, MPH</a> 💪
MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

What's new in enhancing gynecologic outcomes? Meet our experts, Drs. Lauren Colbert and Ann Klopp, in booth 741 to learn more at 11 a.m. EDT. Lauren E. Colbert, MD MSCR Ann Klopp (3/4) #ASTRO24 #EndCancer

What's new in enhancing gynecologic outcomes? 

Meet our experts, Drs. Lauren Colbert and Ann Klopp, in booth 741 to learn more at 11 a.m. EDT. <a href="/colbertle/">Lauren E. Colbert, MD MSCR</a> <a href="/AnnKloppMD/">Ann Klopp</a> (3/4) #ASTRO24 #EndCancer
Albert Koong, MD PhD (@ackoongmdphd) 's Twitter Profile Photo

Persister cells after neoadjuvant treatment for pancreatic cancer are enriched in genes involved in #ferroptosis and #cuproptosis. Fantastic translational study by ⁦Vince Bernard-Pagan, MD PHD⁩ from ⁦MD Anderson Cancer Center⁩. #ASTRO24 #endcancer #radonc

Persister cells after neoadjuvant treatment for pancreatic cancer are enriched in genes involved in #ferroptosis and #cuproptosis. Fantastic translational study by ⁦<a href="/Vince_BernPag/">Vince Bernard-Pagan, MD PHD</a>⁩ from ⁦<a href="/MDAndersonNews/">MD Anderson Cancer Center</a>⁩. #ASTRO24 #endcancer #radonc
Lauren E. Colbert, MD MSCR (@colbertle) 's Twitter Profile Photo

Fantastic work by one of our PGY5 aspiring physician scientists! Vince Bernard-Pagan, MD PHD is the real deal and a total phys sci superstar - it’s amazing to see this project develop from the beginning to these great discoveries and looking forward to how his work will impact patients

MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

Dr. Benjamin Schrank explains his recent research on a first-in-class antibody-drug conjugate that is designed to trigger an immune response, as a complementary strategy to radiation therapy. Read more: bit.ly/3XXRmWW Benjamin Schrank, MD, PhD #ASTRO24 #EndCancer

Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE (@bettykimlab) 's Twitter Profile Photo

MD Anderson Cancer Center Benjamin Schrank, MD, PhD Benjamin Schrank, MD, PhD is without a doubt one of the very best physician scientist trainee I have ever encountered. Quadruple threat: great scientist, leadership skills, gifted educator and super kind/humble. Truly exceptional. He’s also on the job market. So proud!

Chelsea C Pinnix MD PhD (@chelseapinnix) 's Twitter Profile Photo

Brilliant presentation by MD Anderson Cancer Center #RadOnc PGY5 resident Benjamin Schrank, MD, PhD today. This is the FIRST antibody-drug conjugate specifically designed to enhance immune activation against cancer. LET’S GOOOO! @wenjiang_nano Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE Albert Koong, MD PhD #ASTRO24

Brilliant presentation by <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> #RadOnc PGY5 resident <a href="/BenjaminSchrank/">Benjamin Schrank, MD, PhD</a> today. This is the FIRST antibody-drug conjugate specifically designed to enhance immune activation against cancer. LET’S GOOOO! @wenjiang_nano <a href="/BettyKimLab/">Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE</a> <a href="/ACKoongMDPhD/">Albert Koong, MD PhD</a> #ASTRO24
Allison (Allie) Judge (@postdoctorallie) 's Twitter Profile Photo

Do you want to use patient-derived organoids to model cervical cancer? Our group (study led by staff scientist Rui Wang!) did the hard troubleshooting for you and published it as an easy-to-follow protocol 🤗 star-protocols.cell.com/protocols/3754